Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Titan FCOI Policy
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
  • Search

Press Releases

  • Home
  • Investors
  • News / Events
  • Press Releases
Investors

Navigate Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals and Walter Reed Army Institute of Research Collaborate to Evaluate ProNeura Antimalarial Implants

July 6, 2017

Fortune Article Highlights Titan Pharmaceuticals And Its ProNeura Technology

June 29, 2017

Titan Pharmaceuticals Reports First Quarter 2017 Financial Results

May 10, 2017

Titan Pharmaceuticals Schedules Conference Call To Review First Quarter 2017 Financial Results

May 4, 2017

Titan Pharmaceuticals Reports Full Year And Fourth Quarter 2016 Financial Results

March 16, 2017

Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2016 Financial Results

March 10, 2017

Titan Pharmaceuticals To Present At 29th Annual ROTH Conference

March 7, 2017

Titan Pharmaceuticals Receives FDA Communication On Ropinirole Implant Investigational New Drug Application

February 27, 2017

Titan Pharmaceuticals Appoints Two New Board Members

January 4, 2017

Titan Pharmaceuticals Reports Third Quarter 2016 Financial Results

November 9, 2016

RSS
  • « Previous
  • 1...
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • ...24
  • Next »
© 2022 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap